Formulary

MHE’s Most-Read Oncology News in 2020

December 29, 2020

Drug and diagnostic approvals and biosimilars news were popular with readers.

CVS Health’s Prem Shah Talks Specialty Pharmacy During COVID-19

December 27, 2020

How the pandemic has accelerated innovation, and how CVS Health is preparing to delivery vaccines for COVID-19.

FDA Updates: Moderna COVID-19 Vaccine EUA Caps Busy Week

December 20, 2020

The second mRNA vaccine, which does not need the extreme refrigeration of the Pfizer product, began rolling out of a warehouse in Mississippi early Sunday. Friday brought other late-year approvals in cancer treatment.

FDA Updates: Orladeyo in Hereditary Angioedema; Priority Review for Pfizer Pneumococcal Vaccine

December 13, 2020

Pfizer's other vaccine news of the week involves pneumococcal disease.

Accumulator, Maximizer Regulation Picks up at the State Level

December 12, 2020

The five states have moved to prohibit accumulators and maximizers as the federal government takes a hands-off approach, according to John “Jack” S. Linehan, a lawyer at Epstein Becker Green, who is featured in this second part of a two-part video series.

How COVID-19 Is Affecting Those with Opioid Use Disorder

December 02, 2020

As the world remains battling the coronavirus pandemic, there are still significant and unmet needs for those fighting chronic conditions and disorders like opioid use disorder (OUD).

FDA Updates: Approvals in Rare Disorders; Expanded Approval for Flu Treatment

November 29, 2020

FDA approves several drugs to treat rare conditions in both cancer and metabolic diseases.

Insurers Take up Mantle to Ensure Immunizations

November 23, 2020

Health plans build strategies to ensure their beneficiaries have easy access to and receive vital immunizations.

COVID-19 Updates: Trump Adviser Says Vaccines Could Ship Quickly; FDA Grants Emergency Use for Regeneron Cocktail

November 22, 2020

If Pfizer's vaccine gets an emergency use authorization, it could reach sites designated by states within a day.

FDA Updates: Alkermes Gets CRL on Manufacturing Issues; Missed Deadline on Liso-Cel; Lupin Seeks New Solosec Indication

November 17, 2020

Manufacturing issue creates setback for Alkermes on much-anticipated therapy that mitigates weight gain.

FDA Updates: COVID-19 Drug Approval, Priority Review for Tagrisso in New Indication

October 25, 2020

Gilead's Veklury gets full approval; AstraZeneca's Tagrisso heads toward second indication in NSCLC; another use for experimental antifungal therapy.

FDA Updates: ALKS 3831 Wins Joint Panel Nod; Regeneron, Lilly Seek EUAs for Anti-COVID Antibodies

October 11, 2020

The PDUFA date for Alkermes' combination therapy is November 15, 2020.

Real-World Evidence: A Reality Check

September 29, 2020

Can data mined from EHRs match that from the gold standard, randomized clinical trials?

FDA Updates: Approval to Treat Rare Blood Disorders; Label Change for Benzodiazepines

September 27, 2020

Approval for treatment of HES, update to address addictive nature of benzodiazepines.

FDA Update: Report Claims “Power Grab,” Dems Say Hahn Blocked From Testifying

September 20, 2020

Reports say Azar is asserting control over FDA as vaccine trials near completion, while Hahn is blocked from testifying on COVID-19.

The Challenges of Treating Primary Progressive MS

September 13, 2020

A session at MSVirtual2020 covers the difficulty of finding treatments for some forms of MS.

5 Takeaways From the European Society of Cardiology 2020 Congress

September 02, 2020

The 2020 meeting, presented in a virtual format from its original host city of Amsterdam, The Netherlands, had lots of important science and a record number of viewers.

Electronic Prior Authorization is Catching on

August 27, 2020

But there are plenty of holdouts. Half of submissions are still done by phone or fax.

ViiV Healthcare Receives FDA Approval for Drug to Treat Adults with HIV-1

August 08, 2020

Dovato lets adults with HIV reduce the number of antiretroviral therapies they take, while maintaining efficacy and a high barrier to resistance comparable to tenofovir-based regimens.

An Update for Cardiologists Who See Patients With Type 2 Diabetes

August 05, 2020

The American College of Cardiology issues its second set of recommendations for its members on prescribing two groups of drugs first developed for type 2 diabetes.